Compass Therapeutics (CMPX) Times Interest Earned (2018 - 2021)

Compass Therapeutics has disclosed Times Interest Earned across 4 years of filings, most recently posting -$333.36 for Q4 2021.

• Times Interest Earned for Q4 2021 came in at -$333.36, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was -$1071.0 (down 765.47% YoY), and the FY2021 annual result was -$221.3, down 622.5% from the prior year.
• Times Interest Earned came in at -$333.36 for Q4 2021 at Compass Therapeutics, down from -$75.05 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of -$7.09 in Q4 2019 to a low of -$333.36 in Q4 2021.
• The 4-year median for Times Interest Earned is -$24.0 (2019), against an average of -$53.36.
• Peak annual rise in Times Interest Earned reached 33.06% in 2019, while the deepest fall reached 166.1% in 2019.
• Compass Therapeutics' Times Interest Earned stood at -$10.59 in 2018, then surged by 33.06% to -$7.09 in 2019, then tumbled by 496.17% to -$42.27 in 2020, then sank by 688.66% to -$333.36 in 2021.
• The last three Times Interest Earned figures came in at -$333.36 (Q4 2021), -$75.05 (Q3 2021), and -$51.68 (Q1 2021), per Business Quant data.